Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (71-80 of 197) with videos related to

Pageof 20
Sort By:
Journal of Autoimmunity|July 4, 2016
A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cellsCharlotte Hua, Rachel Audo, Nataliya Yeremenko, et al.
Rheumatology (Oxford, England)|February 11, 2015
Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patientsCharlotte Hua, Jacques Morel, Elodie Ardouin, et al.
Arthritis Research & Therapy|November 16, 2019
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohortCédric Lukas, Julia Mary, Michel Debandt, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE RegistryCédric Lukas, Manon Redondin, Isabelle Pane, et al.
Joint Bone Spine|March 31, 2012
Which treatments had been tapered or stopped in rheumatoid arthritis in long-term DAS28 remission following subcutaneous tumor-necrosis-factor blocker therapy? A retrospective experience on 43 patientsSanae Ali Ou Alla, Cedric Lukas, Najia Hajjaj-Hassouni, et al.
Arthritis Research & Therapy|July 30, 2015
Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohortRachel Audo, Claire Daien, Laura Papon, et al.
Arthritis Research & Therapy|June 8, 2019
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohortGaël Mouterde, Nathalie Rincheval, Cédric Lukas, et al.
Immunologic Research|January 23, 2021
IL-10-producing regulatory B cells are present and functional in primary Sjögren patientsJulie Mielle, Anaïz Nutz, Philippe Guillpain, et al.
Arthritis Care & Research|September 22, 2021
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-AnalysisAmélie Wetzman, Cédric Lukas, Cécile Gaujoux-Viala, et al.
The Analyst|January 9, 2020
An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresisMeriem Dadouch, Yoann Ladner, Claudia Bich, et al.
Pageof 20

Showing results (71-80 of 197) with videos related to

Sort By:
Pageof 20
Journal of Autoimmunity|July 4, 2016
A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cellsCharlotte Hua, Rachel Audo, Nataliya Yeremenko, et al.
Rheumatology (Oxford, England)|February 11, 2015
Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patientsCharlotte Hua, Jacques Morel, Elodie Ardouin, et al.
Arthritis Research & Therapy|November 16, 2019
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohortCédric Lukas, Julia Mary, Michel Debandt, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE RegistryCédric Lukas, Manon Redondin, Isabelle Pane, et al.
Joint Bone Spine|March 31, 2012
Which treatments had been tapered or stopped in rheumatoid arthritis in long-term DAS28 remission following subcutaneous tumor-necrosis-factor blocker therapy? A retrospective experience on 43 patientsSanae Ali Ou Alla, Cedric Lukas, Najia Hajjaj-Hassouni, et al.
Arthritis Research & Therapy|July 30, 2015
Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohortRachel Audo, Claire Daien, Laura Papon, et al.
Arthritis Research & Therapy|June 8, 2019
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohortGaël Mouterde, Nathalie Rincheval, Cédric Lukas, et al.
Immunologic Research|January 23, 2021
IL-10-producing regulatory B cells are present and functional in primary Sjögren patientsJulie Mielle, Anaïz Nutz, Philippe Guillpain, et al.
Arthritis Care & Research|September 22, 2021
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-AnalysisAmélie Wetzman, Cédric Lukas, Cécile Gaujoux-Viala, et al.
The Analyst|January 9, 2020
An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresisMeriem Dadouch, Yoann Ladner, Claudia Bich, et al.
Pageof 20